Cargando…
CEMRA in neonatal and pediatric congenital vascular diseases at 1.5T and 3.0T: comparison of an intravascular contrast agent (Gadofosveset) with an extracellular agent (Gadopentetate Dimeglumine)
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3559914/ http://dx.doi.org/10.1186/1532-429X-15-S1-P284 |
_version_ | 1782257687872929792 |
---|---|
author | Khan, Sarah N DaSilva, Carlos Finn, J Paul |
author_facet | Khan, Sarah N DaSilva, Carlos Finn, J Paul |
author_sort | Khan, Sarah N |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-3559914 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2013 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-35599142013-02-01 CEMRA in neonatal and pediatric congenital vascular diseases at 1.5T and 3.0T: comparison of an intravascular contrast agent (Gadofosveset) with an extracellular agent (Gadopentetate Dimeglumine) Khan, Sarah N DaSilva, Carlos Finn, J Paul J Cardiovasc Magn Reson Poster Presentation BioMed Central 2013-01-30 /pmc/articles/PMC3559914/ http://dx.doi.org/10.1186/1532-429X-15-S1-P284 Text en Copyright ©2013 Khan et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Poster Presentation Khan, Sarah N DaSilva, Carlos Finn, J Paul CEMRA in neonatal and pediatric congenital vascular diseases at 1.5T and 3.0T: comparison of an intravascular contrast agent (Gadofosveset) with an extracellular agent (Gadopentetate Dimeglumine) |
title | CEMRA in neonatal and pediatric congenital vascular diseases at 1.5T and 3.0T: comparison of an intravascular contrast agent (Gadofosveset) with an extracellular agent (Gadopentetate Dimeglumine) |
title_full | CEMRA in neonatal and pediatric congenital vascular diseases at 1.5T and 3.0T: comparison of an intravascular contrast agent (Gadofosveset) with an extracellular agent (Gadopentetate Dimeglumine) |
title_fullStr | CEMRA in neonatal and pediatric congenital vascular diseases at 1.5T and 3.0T: comparison of an intravascular contrast agent (Gadofosveset) with an extracellular agent (Gadopentetate Dimeglumine) |
title_full_unstemmed | CEMRA in neonatal and pediatric congenital vascular diseases at 1.5T and 3.0T: comparison of an intravascular contrast agent (Gadofosveset) with an extracellular agent (Gadopentetate Dimeglumine) |
title_short | CEMRA in neonatal and pediatric congenital vascular diseases at 1.5T and 3.0T: comparison of an intravascular contrast agent (Gadofosveset) with an extracellular agent (Gadopentetate Dimeglumine) |
title_sort | cemra in neonatal and pediatric congenital vascular diseases at 1.5t and 3.0t: comparison of an intravascular contrast agent (gadofosveset) with an extracellular agent (gadopentetate dimeglumine) |
topic | Poster Presentation |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3559914/ http://dx.doi.org/10.1186/1532-429X-15-S1-P284 |
work_keys_str_mv | AT khansarahn cemrainneonatalandpediatriccongenitalvasculardiseasesat15tand30tcomparisonofanintravascularcontrastagentgadofosvesetwithanextracellularagentgadopentetatedimeglumine AT dasilvacarlos cemrainneonatalandpediatriccongenitalvasculardiseasesat15tand30tcomparisonofanintravascularcontrastagentgadofosvesetwithanextracellularagentgadopentetatedimeglumine AT finnjpaul cemrainneonatalandpediatriccongenitalvasculardiseasesat15tand30tcomparisonofanintravascularcontrastagentgadofosvesetwithanextracellularagentgadopentetatedimeglumine |